Moriya, K.; Nagamatsu, S.; Nishio, Y.; Komeda, Y.; Kikukawa, S.; Matsuura, K.; Matsuo, H.; Uejima, M.; Kitagawa, T.; Nakamura, F.
Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis. J. Clin. Med. 2025, 14, 874.
https://doi.org/10.3390/jcm14030874
AMA Style
Moriya K, Nagamatsu S, Nishio Y, Komeda Y, Kikukawa S, Matsuura K, Matsuo H, Uejima M, Kitagawa T, Nakamura F.
Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis. Journal of Clinical Medicine. 2025; 14(3):874.
https://doi.org/10.3390/jcm14030874
Chicago/Turabian Style
Moriya, Kei, Shinsaku Nagamatsu, Yuya Nishio, Yusuke Komeda, Shoma Kikukawa, Kyohei Matsuura, Hideki Matsuo, Masakazu Uejima, Takamichi Kitagawa, and Fumihiko Nakamura.
2025. "Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis" Journal of Clinical Medicine 14, no. 3: 874.
https://doi.org/10.3390/jcm14030874
APA Style
Moriya, K., Nagamatsu, S., Nishio, Y., Komeda, Y., Kikukawa, S., Matsuura, K., Matsuo, H., Uejima, M., Kitagawa, T., & Nakamura, F.
(2025). Efficacy of Serum BDNF for the Evaluation of Depressive Neurological Symptoms in Patients with Refractory Ulcerative Colitis. Journal of Clinical Medicine, 14(3), 874.
https://doi.org/10.3390/jcm14030874